Host factors mediating HIV-1 replication

Virus Research

Volumn 161, Issue 2, 2011, Pages 101-114

  Friedrich, Brian M ^a   Dziuba, Natallia ^a   Li, Guangyu ^a   Endsley, Mark A ^a   Murray, James L ^b   Ferguson, Monique R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Zirus Inc   (United States)

Author keywords

Cellular factors; HIV 1 replication; Virus host interactions

Indexed keywords

ACTIN; ACTIN RELATED PROTEIN 2-3 COMPLEX; ADAM10 ENDOPEPTIDASE; BARRIER TO AUTOINTEGRATION FACTOR; CD209 ANTIGEN; CD63 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLOPHILIN A; EMERIN; GALECTIN 1; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP A1B PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE DEACETYLASE 1; KARYOPHERIN; LENS EPITHELIUM DERIVED GROWTH FACTOR; MARAVIROC; MEMBRANE PROTEIN; NUCLEOPORIN; PEPTIDYLPROLYL ISOMERASE PIN1; POLYPEPTIDE; PROTEIN GP340; PROTEIN LAP2 ALPHA; PROTEIN P75; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SURVIVAL MOTOR NEURON PROTEIN 1; TRANSFER RNA; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

CONFORMATIONAL TRANSITION; HISTONE METHYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION; REVIEW; RNA PROCESSING; UBIQUITINATION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS LATENCY; VIRUS REPLICATION; VIRUS UNCOATING;

ANIMALS; ANTI-HIV AGENTS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEINS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80053132394     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.08.001     Document Type: Review

References (257)

1. Aagaard L., Laible G., Selenko P., Schmid M., Dorn R., Schotta G., Kuhfittig S., Wolf A., Lebersorger A., Singh P.B., Reuter G., Jenuwein T. Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31. EMBO J. 1999, 18(7):1923-1938.
2. Abdool Karim Q., Abdool Karim S.S., Frohlich J.A., Grobler A.C., Baxter C., Mansoor L.E., Kharsany A.B., Sibeko S., Mlisana K.P., Omar Z., Gengiah T.N., Maarschalk S., Arulappan N., Mlotshwa M., Morris L., Taylor D. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329(5996):1168-1174.
3. Abouzied M.M., Baader S.L., Dietz F., Kappler J., Gieselmann V., Franken S. Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity. Biochem. J 2004, 378(Pt. 1):169-176.
4. Agostini I., Popov S., Li J., Dubrovsky L., Hao T., Bukrinsky M. Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex. Exp. Cell Res. 2000, 259(2):398-403.
5. Al-Mawsawi L.Q., Neamati N. Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy. Trends Pharmacol. Sci. 2007, 28(10):526-535.
6. Angelov D., Charra M., Seve M., Cote J., Khochbin S., Dimitrov S. Differential remodeling of the HIV-1 nucleosome upon transcription activators and SWI/SNF complex binding. J. Mol. Biol. 2000, 302(2):315-326.
7. Ao Z., Danappa Jayappa K., Wang B., Zheng Y., Kung S., Rassart E., Depping R., Kohler M., Cohen E.A., Yao X. Importin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replication. J. Virol. 2010, 84(17):8650-8663.
8. Ao Z., Huang G., Yao H., Xu Z., Labine M., Cochrane A.W., Yao X. Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication. J. Biol. Chem. 2007, 282(18):13456-13467.
9. Arhel N. Revisiting HIV-1 uncoating. Retrovirology 2010, 7:96.
10. Armstrong J. How do Rab proteins function in membrane traffic?. Int. J. Biochem. Cell Biol. 2000, 32(3):303-307.
11. Askjaer P., Bachi A., Wilm M., Bischoff F.R., Weeks D.L., Ogniewski V., Ohno M., Niehrs C., Kjems J., Mattaj I.W., Fornerod M. RanGTP-regulated interactions of CRM1 with nucleoporins and a shuttling DEAD-box helicase. Mol. Cell. Biol. 1999, 19(9):6276-6285.
12. Auxilien S., Keith G., Le Grice S.F., Darlix J.L. Role of post-transcriptional modifications of primer tRNALys,3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription. J. Biol. Chem. 1999, 274(7):4412-4420.
13. Babst M., Odorizzi G., Estepa E.J., Emr S.D. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 2000, 1(3):248-258.
14. Bannwarth S., Laine S., Daher A., Grandvaux N., Clerzius G., Leblanc A.C., Hiscott J., Gatignol A. Cell-specific regulation of TRBP1 promoter by NF-Y transcription factor in lymphocytes and astrocytes. J. Mol. Biol. 2006, 355(5):898-910.
15. Batoko H., Zheng H.Q., Hawes C., Moore I. A rab1 GTPase is required for transport between the endoplasmic reticulum and Golgi apparatus and for normal Golgi movement in plants. Plant Cell 2000, 12(11):2201-2218.
16. Bauby H., Lopez-Verges S., Hoeffel G., Delcroix-Genete D., Janvier K., Mammano F., Hosmalin A., Berlioz-Torrent C. TIP47 is required for the production of infectious HIV-1 particles from primary macrophages. Traffic 2010, 11(4):455-467.
17. Bazan H.A., Alkhatib G., Broder C.C., Berger E.A. Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates. J. Virol. 1998, 72(5):4485-4491.
18. Beddow A.L., Richards S.A., Orem N.R., Macara I.G. The Ran/TC4 GTPase-binding domain: identification by expression cloning and characterization of a conserved sequence motif. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(8):3328-3332.
19. Berro R., Kehn K., de la Fuente C., Pumfery A., Adair R., Wade J., Colberg-Poley A.M., Hiscott J., Kashanchi F. Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. J. Virol. 2006, 80(7):3189-3204.
20. Bjorndal A., Deng H., Jansson M., Fiore J.R., Colognesi C., Karlsson A., Albert J., Scarlatti G., Littman D.R., Fenyo E.M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 1997, 71(10):7478-7487.
21. Bogerd H.P., Echarri A., Ross T.M., Cullen B.R. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. J. Virol. 1998, 72(11):8627-8635.
22. Borner K., Hermle J., Sommer C., Brown N.P., Knapp B., Glass B., Kunkel J., Torralba G., Reymann J., Beil N., Beneke J., Pepperkok R., Schneider R., Ludwig T., Hausmann M., Hamprecht F., Erfle H., Kaderali L., Krausslich H.G., Lehmann M.J. From experimental setup to bioinformatics: an RNAi screening platform to identify host factors involved in HIV-1 replication. Biotechnol. J. 2010, 5(1):39-49.
23. Bozkulak E.C., Weinmaster G. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol. Cell. Biol. 2009, 29(21):5679-5695.
24. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319(5865):921-926.
25. Briones M.S., Dobard C.W., Chow S.A. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core. J. Virol. 2010, 84(10):5181-5190.
26. Bruce J.W., Ahlquist P., Young J.A. The host cell sulfonation pathway contributes to retroviral infection at a step coincident with provirus establishment. PLoS Pathog. 2008, 4(11):e1000207.
27. Brule F., Marquet R., Rong L., Wainberg M.A., Roques B.P., Le Grice S.F., Ehresmann B., Ehresmann C. Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex. RNA 2002, 8(1):8-15.
28. Bukrinskaya A., Brichacek B., Mann A., Stevenson M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 1998, 188(11):2113-2125.
29. Bukrinsky M., Sharova N., Stevenson M. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. J. Virol. 1993, 67(11):6863-6865.
30. Bushman F.D., Malani N., Fernandes J., D'Orso I., Cagney G., Diamond T.L., Zhou H., Hazuda D.J., Espeseth A.S., Konig R., Bandyopadhyay S., Ideker T., Goff S.P., Krogan N.J., Frankel A.D., Young J.A., Chanda S.K. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5(5):e1000437.
31. Calman A.F., Busch M.P., Vyas G.N., McHugh T.M., Stites D.P., Peterlin B.M. Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro. AIDS 1988, 2(3):185-193.
32. Cannon G., Yi Y., Ni H., Stoddard E., Scales D.A., Van Ryk D.I., Chaiken I., Malamud D., Weissman D. HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection. J. Immunol. 2008, 181(3):2065-2070.
33. Cartegni L., Maconi M., Morandi E., Cobianchi F., Riva S., Biamonti G. hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J. Mol. Biol. 1996, 259(3):337-348.
34. Cartier C., Sivard P., Tranchat C., Decimo D., Desgranges C., Boyer V. Identification of three major phosphorylation sites within HIV-1 capsid Role of phosphorylation during the early steps of infection. J. Biol. Chem. 1999, 274(27):19434-19440.
35. Chan S.Y., Speck R.F., Power C., Gaffen S.L., Chesebro B., Goldsmith M.A. V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1. J. Virol. 1999, 73(3):2350-2358.
36. Chaudhry A., Das S.R., Jameel S., George A., Bal V., Mayor S., Rath S. HIV-1 Nef induces a Rab11-dependent routing of endocytosed immune costimulatory proteins CD80 and CD86 to the Golgi. Traffic 2008, 9(11):1925-1935.
37. Chen H., Engelman A. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(26):15270-15274.
38. Cherepanov P., Devroe E., Silver P.A., Engelman A. Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase. J. Biol. Chem. 2004, 279(47):48883-48892.
39. Ciuffi A., Llano M., Poeschla E., Hoffmann C., Leipzig J., Shinn P., Ecker J.R., Bushman F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 2005, 11(12):1287-1289.
40. Col E., Caron C., Seigneurin-Berny D., Gracia J., Favier A., Khochbin S. The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J. Biol. Chem. 2001, 276(30):28179-28184.
41. Coull J.J., Romerio F., Sun J.M., Volker J.L., Galvin K.M., Davie J.R., Shi Y., Hansen U., Margolis D.M. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J. Virol. 2000, 74(15):6790-6799.
42. Daelemans D., Afonina E., Nilsson J., Werner G., Kjems J., De Clercq E., Pavlakis G.N., Vandamme A.M. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(22):14440-14445.
43. Daniel D.C., Wortman M.J., Schiller R.J., Liu H., Gan L., Mellen J.S., Chang C.F., Gallia G.L., Rappaport J., Khalili K., Johnson E.M. Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin. J. Gen. Virol. 2001, 82(Pt. 7):1543-1553.
44. de Witte L., Nabatov A., Geijtenbeek T.B. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol. Med. 2008, 14(1):12-19.
45. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273(5283):1856-1862.
46. Dell'Angelica E.C., Ohno H., Ooi C.E., Rabinovich E., Roche K.W., Bonifacino J.S. AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J. 1997, 16(5):917-928.
47. Denton P.W., Othieno F., Martinez-Torres F., Zou W., Krisko J.F., Fleming E., Zein S., Powell D.A., Wahl A., Kwak Y.T., Welch B.D., Kay M.S., Payne D.A., Gallay P., Appella E., Estes J.D., Lu M., Garcia J.V. One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J. Virol. 2011, 85(15):7582-7593.
48. Dietz F., Franken S., Yoshida K., Nakamura H., Kappler J., Gieselmann V. The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies. Biochem. J 2002, 366(Pt. 2):491-500.
49. Dong J., Lai R., Nielsen K., Fekete C.A., Qiu H., Hinnebusch A.G. The essential ATP-binding cassette protein RLI1 functions in translation by promoting preinitiation complex assembly. J. Biol. Chem. 2004, 279(40):42157-42168.
50. Dong X., Li H., Derdowski A., Ding L., Burnett A., Chen X., Peters T.R., Dermody T.S., Woodruff E., Wang J.J., Spearman P. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 2005, 120(5):663-674.
51. Dooher J.E., Schneider B.L., Reed J.C., Lingappa J.R. Host ABCE1 is at plasma membrane HIV assembly sites and its dissociation from Gag is linked to subsequent events of virus production. Traffic 2007, 8(3):195-211.
52. Dussart S., Courcoul M., Bessou G., Douaisi M., Duverger Y., Vigne R., Decroly E. The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin. Biochem. Biophys. Res. Commun. 2004, 315(1):66-72.
53. Edinger A.L., Hoffman T.L., Sharron M., Lee B., Yi Y., Choe W., Kolson D.L., Mitrovic B., Zhou Y., Faulds D., Collman R.G., Hesselgesser J., Horuk R., Doms R.W. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 1998, 72(10):7934-7940.
54. Fagerlund R., Kinnunen L., Kohler M., Julkunen I., Melen K. NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4. J. Biol. Chem. 2005, 280(16):15942-15951.
55. Farnet C.M., Bushman F.D. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 1997, 88(4):483-492.
56. Fassati A., Gorlich D., Harrison I., Zaytseva L., Mingot J.M. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J. 2003, 22(14):3675-3685.
57. Fatma N., Singh D.P., Shinohara T., Chylack L.T. Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress. J. Biol. Chem. 2001, 276(52):48899-48907.
58. Ferguson M.R., Rojo D.R., von Lindern J.J., O'Brien W.A. HIV-1 replication cycle. Clin. Lab. Med. 2002, 22(3):611-635.
59. Fischle W., Wang Y., Allis C.D. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 2003, 15(2):172-183.
60. Fisher R.D., Chung H.Y., Zhai Q., Robinson H., Sundquist W.I., Hill C.P. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 2007, 128(5):841-852.
61. Flaus A., Owen-Hughes T. Mechanisms for ATP-dependent chromatin remodelling. Curr. Opin. Genet. Dev. 2001, 11(2):148-154.
62. Foisner R., Gerace L. Integral membrane proteins of the nuclear envelope interact with lamins and chromosomes, and binding is modulated by mitotic phosphorylation. Cell 1993, 73(7):1267-1279.
63. Freedman N.D., Yamamoto K.R. Importin 7 and importin alpha/importin beta are nuclear import receptors for the glucocorticoid receptor. Mol. Biol. Cell 2004, 15(5):2276-2286.
64. Friedmann M., Holth L.T., Zoghbi H.Y., Reeves R. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res. 1993, 21(18):4259-4267.
65. Friedrich B., Li G., Dziuba N., Ferguson M.R. Quantitative PCR used to assess HIV-1 integration and 2-LTR circle formation in human macrophages, peripheral blood lymphocytes and a CD4+ cell line. Virol. J. 2010, 7:354.
66. Friedrich B.M., Murray J.L., Li G., Sheng J., Hodge T.W., Rubin D.H., O'Brien W.A., Ferguson M.R. A functional role for ADAM10 in human immunodeficiency virus type-1 replication. Retrovirology 2011, 8:32.
67. Fujii K., Munshi U.M., Ablan S.D., Demirov D.G., Soheilian F., Nagashima K., Stephen A.G., Fisher R.J., Freed E.O. Functional role of Alix in HIV-1 replication. Virology 2009, 391(2):284-292.
68. Gallay P., Hope T., Chin D., Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(18):9825-9830.
69. Gallay P., Stitt V., Mundy C., Oettinger M., Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 1996, 70(2):1027-1032.
70. Gallia G.L., Darbinian N., Tretiakova A., Ansari S.A., Rappaport J., Brady J., Wortman M.J., Johnson E.M., Khalili K. Association of HIV-1 Tat with the cellular protein Puralpha, is mediated by RNA. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(20):11572-11577.
71. Garin M.I., Chu C.C., Golshayan D., Cernuda-Morollon E., Wait R., Lechler R.I. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 2007, 109(5):2058-2065.
72. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001, 107(1):55-65.
73. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100(5):587-597.
74. Gottwein E., Jager S., Habermann A., Krausslich H.G. Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect. J. Virol. 2006, 80(13):6267-6275.
75. Grigorov B., Arcanger F., Roingeard P., Darlix J.L., Muriaux D. Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J. Mol. Biol. 2006, 359(4):848-862.
76. Gruenheid S., Finlay B.B. Microbial pathogenesis and cytoskeletal function. Nature 2003, 422(6933):775-781.
77. Hakata Y., Yamada M., Mabuchi N., Shida H. The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions. J. Virol. 2002, 76(16):8079-8089.
78. Hales C.M., Griner R., Hobdy-Henderson K.C., Dorn M.C., Hardy D., Kumar R., Navarre J., Chan E.K., Lapierre L.A., Goldenring J.R. Identification and characterization of a family of Rab11-interacting proteins. J. Biol. Chem. 2001, 276(42):39067-39075.
79. Hamamoto S., Nishitsuji H., Amagasa T., Kannagi M., Masuda T. Identification of a novel human immunodeficiency virus type 1 integrase interactor Gemin2, that facilitates efficient viral cDNA synthesis in vivo. J. Virol. 2006, 80(12):5670-5677.
80. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984, 226(4674):544-547.
81. Harrich D., Garcia J., Wu F., Mitsuyasu R., Gonazalez J., Gaynor R. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 1989, 63(6):2585-2591.
82. Harris D., Engelman A. Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro. J. Biol. Chem. 2000, 275(50):39671-39677.
83. Harrist A.V., Ryzhova E.V., Harvey T., Gonzalez-Scarano F. Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cells. PLoS One 2009, 4(3):e5020.
84. Hearps A.C., Jans D.A. HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism. Biochem. J 2006, 398(3):475-484.
85. Hemler M.E. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 2005, 6(10):801-811.
86. Henderson A., Bunce M., Siddon N., Reeves R., Tremethick D.J. High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter. J. Virol. 2000, 74(22):10523-10534.
87. Henderson A., Holloway A., Reeves R., Tremethick D.J. Recruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 2004, 24(1):389-397.
88. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem 1998, 67:425-479.
89. Hicke L., Dunn R. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 2003, 19:141-172.
90. Hindmarsh P., Leis J. Retroviral DNA integration. Microbiol. Mol. Biol. Rev. 1999, 63(4):836-843. (table of contents).
91. Hindmarsh P., Ridky T., Reeves R., Andrake M., Skalka A.M., Leis J. HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J. Virol. 1999, 73(4):2994-3003.
92. Hocsak E., Racz B., Szabo A., Pozsgai E., Szigeti A., Szigeti E., Gallyas F., Sumegi B., Javor S., Bellyei S. TIP47 confers resistance to taxol-induced cell death by preventing the nuclear translocation of AIF and Endonuclease G. Eur. J. Cell Biol. 2010, 89(11):853-861.
93. Hoque M.O., Begum S., Topaloglu O., Jeronimo C., Mambo E., Westra W.H., Califano J.A., Sidransky D. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res. 2004, 64(15):5511-5517.
94. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., Koup R.A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 1996, 2(11):1240-1243.
95. Hurley J.H., Emr S.D. The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu. Rev. Biophys. Biomol. Struct. 2006, 35:277-298.
96. Hutten S., Walde S., Spillner C., Hauber J., Kehlenbach R.H. The nuclear pore component Nup358 promotes transportin-dependent nuclear import. J. Cell Sci. 2009, 122(Pt. 8):1100-1110.
97. Jacque J.M., Stevenson M. The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature 2006, 441(7093):641-645.
98. Jadlowsky J.K., Nojima M., Okamoto T., Fujinaga K. Dominant negative mutant cyclin T1 proteins that inhibit HIV transcription by forming a kinase inactive complex with Tat. J. Gen. Virol. 2008, 89(Pt. 11):2783-2787.
99. Jakel S., Albig W., Kutay U., Bischoff F.R., Schwamborn K., Doenecke D., Gorlich D. The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1. EMBO J. 1999, 18(9):2411-2423.
100. Janeway C.A. The priming of helper T cells. Semin. Immunol. 1989, 1(1):13-20.
101. Jolly C., Sattentau Q.J. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J. Virol. 2007, 81(15):7873-7884.
102. Keckesova Z., Ylinen L.M., Towers G.J. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(29):10780-10785.
103. Keckesova Z., Ylinen L.M., Towers G.J. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity. J. Virol. 2006, 80(10):4683-4690.
104. Kehlenbach R.H., Dickmanns A., Kehlenbach A., Guan T., Gerace L. A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export. J. Cell Biol. 1999, 145(4):645-657.
105. Kerr I.D. Sequence analysis of twin ATP binding cassette proteins involved in translational control, antibiotic resistance, and ribonuclease L inhibition. Biochem. Biophys. Res. Commun. 2004, 315(1):166-173.
106. Kilareski E.M., Shah S., Nonnemacher M.R., Wigdahl B. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009, 6:118.
107. Kleiman L. tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1. IUBMB Life 2002, 53(2):107-114.
108. Kok K.H., Lei T., Jin D.Y. siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication. Retrovirology 2009, 6:78.
109. Komano J., Miyauchi K., Matsuda Z., Yamamoto N. Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol. Biol. Cell 2004, 15(12):5197-5207.
110. Konig R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., Seidel S., Opaluch A.M., Caldwell J.S., Weitzman M.D., Kuhen K.L., Bandyopadhyay S., Ideker T., Orth A.P., Miraglia L.J., Bushman F.D., Young J.A., Chanda S.K. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135(1):49-60.
111. Krachmarov C.P., Chepenik L.G., Barr-Vagell S., Khalili K., Johnson E.M. Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(24):14112-14117.
112. Krebs D.L., Hilton D.J. SOCS: physiological suppressors of cytokine signaling. J. Cell Sci. 2000, 113(Pt. 16):2813-2819.
113. Krishnan V., Zeichner S.L. Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication. Retrovirology 2004, 1:42.
114. Kucia M., Jankowski K., Reca R., Wysoczynski M., Bandura L., Allendorf D.J., Zhang J., Ratajczak J., Ratajczak M.Z. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 2004, 35(3):233-245.
115. Kuersten S., Ohno M., Mattaj I.W. Nucleocytoplasmic transport: ran, beta and beyond. Trends Cell Biol. 2001, 11(12):497-503.
116. Lai M., Zimmerman E.S., Planelles V., Chen J. Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo. J. Virol. 2005, 79(24):15443-15451.
117. Lanchy J.M., Isel C., Ehresmann C., Marquet R., Ehresmann B. Structural and functional evidence that initiation and elongation of HIV-1 reverse transcription are distinct processes. Biochimie 1996, 78(11-12):1087-1096.
118. Lee M.S., Craigie R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(4):1528-1533.
119. Levesque K., Halvorsen M., Abrahamyan L., Chatel-Chaix L., Poupon V., Gordon H., DesGroseillers L., Gatignol A., Mouland A.J. Trafficking of HIV-1 RNA is mediated by heterogeneous nuclear ribonucleoprotein A2 expression and impacts on viral assembly. Traffic 2006, 7(9):1177-1193.
120. Levin A., Armon-Omer A., Rosenbluh J., Melamed-Book N., Graessmann A., Waigmann E., Loyter A. Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal. Retrovirology 2009, 6:112.
121. Li G., Dziuba N., Friedrich B., Murray J.L., Ferguson M.R. A post-entry role for CD63 in early HIV-1 replication. Virology 2011.
122. Li S., Bozzo L., Wu Z., Lu W., Romerio F. The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells. New Microbiol. 2010, 33(1):13-24.
123. Li X.Y., Green M.R. The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. Genes Dev. 1998, 12(19):2992-2996.
124. Li Y., Kar A.K., Sodroski J. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. J. Virol. 2009, 83(21):10951-10962.
125. Liang C., Rong L., Gotte M., Li X., Quan Y., Kleiman L., Wainberg M.A. Mechanistic studies of early pausing events during initiation of HIV-1 reverse transcription. J. Biol. Chem. 1998, 273(33):21309-21315.
126. Liewen H., Meinhold-Heerlein I., Oliveira V., Schwarzenbacher R., Luo G., Wadle A., Jung M., Pfreundschuh M., Stenner-Liewen F. Characterization of the human GARP (Golgi associated retrograde protein) complex. Exp. Cell Res. 2005, 306(1):24-34.
127. Lin C.W., Engelman A. The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes. J. Virol. 2003, 77(8):5030-5036.
128. Lin J.J., Dutta A. ATR pathway is the primary pathway for activating G2/M checkpoint induction after re-replication. J. Biol. Chem. 2007, 282(42):30357-30362.
129. Little S.J., Holte S., Routy J.P., Daar E.S., Markowitz M., Collier A.C., Koup R.A., Mellors J.W., Connick E., Conway B., Kilby M., Wang L., Whitcomb J.M., Hellmann N.S., Richman D.D. Antiretroviral-drug resistance among patients recently infected with HIV. N. Engl. J. Med. 2002, 347(6):385-394.
130. Liu B., Dai R., Tian C.J., Dawson L., Gorelick R., Yu X.F. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J. Virol. 1999, 73(4):2901-2908.
131. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86(3):367-377.
132. Llano M., Delgado S., Vanegas M., Poeschla E.M. Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem. 2004, 279(53):55570-55577.
133. Llano M., Vanegas M., Fregoso O., Saenz D., Chung S., Peretz M., Poeschla E.M. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol. 2004, 78(17):9524-9537.
134. Lounsbury K.M., Macara I.G. Ran-binding protein 1 (RanBP1) forms a ternary complex with Ran and karyopherin beta and reduces Ran GTPase-activating protein (RanGAP) inhibition by karyopherin beta. J. Biol. Chem. 1997, 272(1):551-555.
135. Luban J. HIV-1 infection: going nuclear with TNPO3/Transportin-SR2 and integrase. Curr. Biol. 2008, 18(16):R710-R713.
136. Maertens G., Cherepanov P., Pluymers W., Busschots K., De Clercq E., Debyser Z., Engelborghs Y. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 2003, 278(35):33528-33539.
137. Mak J., Kleiman L. Primer tRNAs for reverse transcription. J. Virol. 1997, 71(11):8087-8095.
138. Mameli G., Deshmane S.L., Ghafouri M., Cui J., Simbiri K., Khalili K., Mukerjee R., Dolei A., Amini S., Sawaya B.E. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9. J. Gen. Virol. 2007, 88(Pt. 2):631-640.
139. Mansharamani M., Graham D.R., Monie D., Lee K.K., Hildreth J.E., Siliciano R.F., Wilson K.L. Barrier-to-autointegration factor BAF binds p55 Gag and matrix and is a host component of human immunodeficiency virus type 1 virions. J. Virol. 2003, 77(24):13084-13092.
140. Marban C., Suzanne S., Dequiedt F., de Walque S., Redel L., Van Lint C., Aunis D., Rohr O. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J. 2007, 26(2):412-423.
141. Margalit A., Brachner A., Gotzmann J., Foisner R., Gruenbaum Y. Barrier-to-autointegration factor-a BAFfling little protein. Trends Cell Biol. 2007, 17(4):202-208.
142. Margalit A., Segura-Totten M., Gruenbaum Y., Wilson K.L. Barrier-to-autointegration factor is required to segregate and enclose chromosomes within the nuclear envelope and assemble the nuclear lamina. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(9):3290-3295.
143. Martin-Serrano J., Zang T., Bieniasz P.D. Role of ESCRT-I in retroviral budding. J. Virol. 2003, 77(8):4794-4804.
144. Mascarenhas A.P., Musier-Forsyth K. The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors. FEBS J. 2009, 276(21):6118-6127.
145. Masso M. DC-SIGN points the way to a novel mechanism for HIV-1 transmission. MedGenMed 2003, 5(2):2.
146. Mayeda A., Krainer A.R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 1992, 68(2):365-375.
147. McDonald D. Dendritic cells and HIV-1 trans-infection. Viruses 2010, 2(8):1704-1717.
148. McDonald D., Vodicka M.A., Lucero G., Svitkina T.M., Borisy G.G., Emerman M., Hope T.J. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 2002, 159(3):441-452.
149. Meehan A.M., Saenz D.T., Morrison J.H., Garcia-Rivera J.A., Peretz M., Llano M., Poeschla E.M. LEDGF/p75 proteins with alternative chromatin tethers are functional HIV-1 cofactors. PLoS Pathog. 2009, 5(7):e1000522.
150. Mercier S., St-Pierre C., Pelletier I., Ouellet M., Tremblay M.J., Sato S. Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. Virology 2008, 371(1):121-129.
151. Michael N.L., Nelson J.A., KewalRamani V.N., Chang G., O'Brien S.J., Mascola J.R., Volsky B., Louder M., White G.C., Littman D.R., Swanstrom R., O'Brien T.R. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J. Virol. 1998, 72(7):6040-6047.
152. Misumi S., Inoue M., Dochi T., Kishimoto N., Hasegawa N., Takamune N., Shoji S. Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1. J. Biol. Chem. 2010, 285(33):25185-25195.
153. Mizukami T., Fuerst T.R., Berger E.A., Moss B. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 1988, 85(23):9273-9277.
154. Monia B., Ecker D., Crooke S. New perspectives on the structure and function of ubiquitin. Biotechnology 1990, 8:209-215.
155. Moutsopoulos N.M., Vazquez N., Greenwell-Wild T., Ecevit I., Horn J., Orenstein J., Wahl S.M. Regulation of the tonsil cytokine milieu favors HIV susceptibility. J. Leukoc. Biol. 2006, 80(5):1145-1155.
156. Mulky A., Cohen T.V., Kozlov S.V., Korbei B., Foisner R., Stewart C.L., KewalRamani V.N. The LEM domain proteins emerin and LAP2alpha are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections. J. Virol. 2008, 82(12):5860-5868.
157. Murray J.L., Mavrakis M., McDonald N.J., Yilla M., Sheng J., Bellini W.J., Zhao L., Le Doux J.M., Shaw M.W., Luo C.C., Lippincott-Schwartz J., Sanchez A., Rubin D.H., Hodge T.W. Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J. Virol. 2005, 79(18):11742-11751.
158. Nakatsu F., Ohno H. Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct. Funct. 2003, 28(5):419-429.
159. Narron J.V., Stoops T.D., Barringhaus K., Matsumura M., Everett A.D. Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration. Pediatr. Res. 2006, 59(6):778-783.
160. Nguyen D.G., Wolff K.C., Yin H., Caldwell J.S., Kuhen K.L. UnPAKing human immunodeficiency virus (HIV) replication: using small interfering RNA screening to identify novel cofactors and elucidate the role of group I PAKs in HIV infection. J. Virol. 2006, 80(1):130-137.
161. Nishitsuji H., Hayashi T., Takahashi T., Miyano M., Kannagi M., Masuda T. Augmentation of reverse transcription by integrase through an interaction with host factor SIP1/Gemin2 is critical for HIV-1 infection. PLoS One 2009, 4(11):e7825.
162. Novick P., Brennwald P. Friends and family: the role of the Rab GTPases in vesicular traffic. Cell 1993, 75(4):597-601.
163. Ojikutu B.O., Stone V.E., Bardeguez A. Women of color and HIV/AIDS: epidemiology, clinical aspects, and management. HIV/AIDS in U.S. Communities of Color 2009, 83-101. Springer, New York, NY. V. Stone, B. Ojikutu, M.K. Rawlings, K.Y. Smith (Eds.).
164. Okunola H.L., Krainer A.R. Cooperative-binding and splicing-repressive properties of hnRNP A1. Mol. Cell. Biol. 2009, 29(20):5620-5631.
165. Oppermann M. Chemokine receptor CCR5: insights into structure, function, and regulation. Cell. Signal. 2004, 16(11):1201-1210.
166. Ott D.E., Coren L.V., Chertova E.N., Gagliardi T.D., Schubert U. Ubiquitination of HIV-1 and MuLV Gag. Virology 2000, 278(1):111-121.
167. Ouellet M., Mercier S., Pelletier I., Bounou S., Roy J., Hirabayashi J., Sato S., Tremblay M.J. Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J. Immunol. 2005, 174(7):4120-4126.
168. Pace M.J., Agosto L., Graf E.H., O'Doherty U. HIV reservoirs and latency models. Virology 2011, 411(2):344-354.
169. Parada C.A., Roeder R.G. A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription. EMBO J. 1999, 18(13):3688-3701.
170. Patnaik A., Chau V., Wills J.W. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(24):13069-13074.
171. Pazin M.J., Kadonaga J.T. What's up and down with histone deacetylation and transcription?. Cell 1997, 89(3):325-328.
172. Pelchen-Matthews A., Kramer B., Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 2003, 162(3):443-455.
173. Percipalle P., Raju C.S., Fukuda N. Actin-associated hnRNP proteins as transacting factors in the control of mRNA transport and localization. RNA Biol. 2009, 6(2):171-174.
174. Pereira L.A, Bentley K., Peeters A., Churchill M.J., Deacon N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 2000, 28(3):663-668.
175. Perlman M., Resh M.D. Identification of an intracellular trafficking and assembly pathway for HIV-1 gag. Traffic 2006, 7(6):731-745.
176. Pessler F., Cron R.Q. Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes Immun. 2004, 5(3):158-167.
177. Petersen-Mahrt S.K., Estmer C., Ohrmalm C., Matthews D.A., Russell W.C., Akusjarvi G. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J. 1999, 18(4):1014-1024.
178. Pincetic A., Kuang Z., Seo E.J., Leis J. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 2010, 84(9):4725-4736.
179. Piper R.C., Katzmann D.J. Biogenesis and function of multivesicular bodies. Annu. Rev. Cell Dev. Biol. 2007, 23:519-547.
180. Piper R.C., Luzio J.P. Late endosomes: sorting and partitioning in multivesicular bodies. Traffic 2001, 2(9):612-621.
181. Polo S., Sigismund S., Faretta M., Guidi M., Capua M.R., Bossi G., Chen H., De Camilli P., Di Fiore P.P. A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature 2002, 416(6879):451-455.
182. Pols M.S., Klumperman J. Trafficking and function of the tetraspanin CD63. Exp. Cell Res. 2009, 315(9):1584-1592.
183. Popov S., Popova E., Inoue M., Gottlinger H.G. Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J. Virol. 2008, 82(3):1389-1398.
184. Popov S., Rexach M., Zybarth G., Reiling N., Lee M.A., Ratner L., Lane C.M., Moore M.S., Blobel G., Bukrinsky M. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 1998, 17(4):909-917.
185. Preston B.D., Poiesz B.J., Loeb L.A. Fidelity of HIV-1 reverse transcriptase. Science 1988, 242(4882):1168-1171.
186. Rabinovich G.A., Iglesias M.M., Modesti N.M., Castagna L.F., Wolfenstein-Todel C., Riera C.M., Sotomayor C.E. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. J. Immunol. 1998, 160(10):4831-4840.
187. Rai T., Mosoian A., Resh M.D. Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell type-dependent role in regulating infectivity. J. Virol. 2010, 84(19):9783-9792.
188. Raiborg C., Rusten T.E., Stenmark H. Protein sorting into multivesicular endosomes. Curr. Opin. Cell Biol. 2003, 15(4):446-455.
189. Raiborg C., Stenmark H. Hrs and endocytic sorting of ubiquitinated membrane proteins. Cell Struct. Funct. 2002, 27(6):403-408.
190. Raposo G., Moore M., Innes D., Leijendekker R., Leigh-Brown A., Benaroch P., Geuze H. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 2002, 3(10):718-729.
191. Rato S., Maia S., Brito P.M., Resende L., Pereira C.F., Moita C., Freitas R.P., Moniz-Pereira J., Hacohen N., Moita L.F., Goncalves J. Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cells. PLoS One 2010, 5(2):e9276.
192. Robichaud G.A., Barbeau B., Fortin J.F., Rothstein D.M., Tremblay M.J. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. J. Biol. Chem. 2002, 277(26):23733-23741.
193. Romano G., Giordano A. Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases. Cell Cycle 2008, 7(23):3664-3668.
194. Ryo A., Tsurutani N., Ohba K., Kimura R., Komano J., Nishi M., Soeda H., Hattori S., Perrem K., Yamamoto M., Chiba J., Mimaya J., Yoshimura K., Matsushita S., Honda M., Yoshimura A., Sawasaki T., Aoki I., Morikawa Y., Yamamoto N. SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(1):294-299.
195. Ryzhova E.V., Vos R.M., Albright A.V., Harrist A.V., Harvey T., Gonzalez-Scarano F. Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages. J. Virol. 2006, 80(6):2694-2704.
196. Salerno D., Hasham M.G., Marshall R., Garriga J., Tsygankov A.Y., Grana X. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes. Gene 2007, 405(1-2):65-78.
197. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382(6593):722-725.
198. Sano M., Schneider M.D. Cyclins that don't cycle-cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size. Cell Cycle 2003, 2(2):99-104.
199. Sato K., Aoki J., Misawa N., Daikoku E., Sano K., Tanaka Y., Koyanagi Y. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J. Virol. 2008, 82(2):1021-1033.
200. Schnell J.D., Hicke L. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J. Biol. Chem. 2003, 278(38):35857-35860.
201. Schroder M. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem. Pharmacol. 2010, 79(3):297-306.
202. Segev N. Coordination of intracellular transport steps by GTPases. Semin. Cell Dev. Biol. 2010, 22(1):33-38.
203. Sgarbanti M., Remoli A.L., Marsili G., Ridolfi B., Borsetti A., Perrotti E., Orsatti R., Ilari R., Sernicola L., Stellacci E., Ensoli B., Battistini A. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J. Virol. 2008, 82(7):3632-3641.
204. Sherer N.M., Lehmann M.J., Jimenez-Soto L.F., Ingmundson A., Horner S.M., Cicchetti G., Allen P.G., Pypaert M., Cunningham J.M., Mothes W. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 2003, 4(11):785-801.
205. Shun M.C., Daigle J.E., Vandegraaff N., Engelman A. Wild-type levels of human immunodeficiency virus type 1 infectivity in the absence of cellular emerin protein. J. Virol. 2007, 81(1):166-172.
206. Singh D.P., Ohguro N., Kikuchi T., Sueno T., Reddy V.N., Yuge K., Chylack L.T., Shinohara T. Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts. Biochem. Biophys. Res. Commun. 2000, 267(1):373-381.
207. Slagsvold T., Pattni K., Malerod L., Stenmark H. Endosomal and non-endosomal functions of ESCRT proteins. Trends Cell Biol. 2006, 16(6):317-326.
208. Smits V.A., Warmerdam D.O., Martin Y., Freire R. Mechanisms of ATR-mediated checkpoint signalling. Front. Biosci. 2010, 15:840-853.
209. Sokolskaja E., Berthoux L., Luban J. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells. J. Virol. 2006, 80(6):2855-2862.
210. Stipp C.S., Kolesnikova T.V., Hemler M.E. Functional domains in tetraspanin proteins. Trends Biochem. Sci. 2003, 28(2):106-112.
211. Stoddard E., Cannon G., Ni H., Kariko K., Capodici J., Malamud D., Weissman D. gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J. Immunol. 2007, 179(5):3126-3132.
212. Stoddard E., Ni H., Cannon G., Zhou C., Kallenbach N., Malamud D., Weissman D. gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J. Virol. 2009, 83(17):8596-8603.
213. Strack B., Calistri A., Craig S., Popova E., Gottlinger H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003, 114(6):689-699.
214. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
215. Stremlau M., Song B., Javanbakht H., Perron M., Sodroski J. Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. Virology 2006, 351(1):112-120.
216. Stutz F., Izaurralde E., Mattaj I.W., Rosbash M. A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus. Mol. Cell. Biol. 1996, 16(12):7144-7150.
217. Sune C., Garcia-Blanco M.A. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 1995, 69(10):6572-6576.
218. Suzuki Y., Craigie R. The road to chromatin-nuclear entry of retroviruses. Nat. Rev. Microbiol. 2007, 5(3):187-196.
219. Takahashi K., Uchida C., Shin R.W., Shimazaki K., Uchida T. Prolyl isomerase Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. Cell. Mol. Life Sci. 2008, 65(3):359-375.
220. Tisne C. Structural bases of the annealing of primer tRNA(3Lys) to the HIV-1 viral RNA. Curr. HIV Res. 2005, 3(2):147-156.
221. Treand C., du Chene I., Bres V., Kiernan R., Benarous R., Benkirane M., Emiliani S. Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J. 2006, 25(8):1690-1699.
222. Trivedi V., Von Lindern J., Montes-Walters M., Rojo D.R., Shell E.J., Parkin N., O'Brien W.A., Ferguson M.R. Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility. AIDS Res. Hum. Retroviruses 2008, 24(10):1291-1300.
223. Trkola A., Dragic T., Arthos J., Binley J.M., Olson W.C., Allaway G.P., Cheng-Mayer C., Robinson J., Maddon P.J., Moore J.P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996, 384(6605):184-187.
224. Tyagi M., Karn J. CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J. 2007, 26(24):4985-4995.
225. Urbe S., Huber L.A., Zerial M., Tooze S.A., Parton R.G. Rab11, a small GTPase associated with both constitutive and regulated secretory pathways in PC12 cells. FEBS Lett. 1993, 334(2):175-182.
226. Vandegraaff N., Devroe E., Turlure F., Silver P.A., Engelman A. Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. Virology 2006, 346(2):415-426.
227. Vanegas M., Llano M., Delgado S., Thompson D., Peretz M., Poeschla E. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J. Cell Sci. 2005, 118(Pt. 8):1733-1743.
228. Varadarajan P., Mahalingam S., Liu P., Ng S.B., Gandotra S., Dorairajoo D.S., Balasundaram D. The functionally conserved nucleoporins Nup124p from fission yeast and the human Nup153 mediate nuclear import and activity of the Tf1 retrotransposon and HIV-1 Vpr. Mol. Biol. Cell 2005, 16(4):1823-1838.
229. Verdin E., Paras P., Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 1993, 12(8):3249-3259.
230. von Lindern J.J., Rojo D., Grovit-Ferbas K., Yeramian C., Deng C., Herbein G., Ferguson M.R., Pappas T.C., Decker J.M., Singh A., Collman R.G., O'Brien W.A. Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J. Virol. 2003, 77(6):3624-3633.
231. von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., Scott A., Krausslich H.G., Kaplan J., Morham S.G., Sundquist W.I. The protein network of HIV budding. Cell 2003, 114(6):701-713.
232. Weiss E.R., Popova E., Yamanaka H., Kim H.C., Huibregtse J.M., Gottlinger H. Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag. PLoS Pathog. 2010, 6(9).
233. Weiss R.A. HIV receptors and cellular tropism. IUBMB Life 2002, 53(4-5):201-205.
234. Welch M.D., Mullins R.D. Cellular control of actin nucleation. Annu. Rev. Cell Dev. Biol. 2002, 18:247-288.
235. White M.K., Johnson E.M., Khalili K. Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle 2009, 8(3):1-7.
236. Williams S.A., Chen L.F., Kwon H., Ruiz-Jarabo C.M., Verdin E., Greene W.C. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 2006, 25(1):139-149.
237. Woodward C.L., Prakobwanakit S., Mosessian S., Chow S.A. Integrase interacts with nucleoporin NUP153 to mediate the nuclear import of human immunodeficiency virus type 1. J. Virol. 2009, 83(13):6522-6533.
238. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996, 384(6605):179-183.
239. Wu Y. HIV-1 gene expression: lessons from provirus and non-integrated DNA. Retrovirology 2004, 1:13.
240. Xu Z.H., Otterness D.M., Freimuth R.R., Carlini E.J., Wood T.C., Mitchell S., Moon E., Kim U.J., Xu J.P., Siciliano M.J., Weinshilboum R.M. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization. Biochem. Biophys. Res. Commun. 2000, 268(2):437-444.
241. Yamaguchi Y., Narita T., Inukai N., Wada T., Handa H. SPT genes: key players in the regulation of transcription, chromatin structure and other cellular processes. J. Biochem. 2001, 129(2):185-191.
242. Yang Y.X., Guen V., Richard J., Cohen E.A., Berthoux L. Cell context-dependent involvement of ATR in early stages of retroviral replication. Virology 2010, 396(2):272-279.
243. Yap M.W., Nisole S., Lynch C., Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(29):10786-10791.
244. Yedavalli V.S., Neuveut C., Chi Y.H., Kleiman L., Jeang K.T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119(3):381-392.
245. Yeung M.L., Houzet L., Yedavalli V.S., Jeang K.T. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J. Biol. Chem. 2009, 284(29):19463-19473.
246. Yu W., Ramakrishnan R., Wang Y., Chiang K., Sung T.L., Rice A.P. Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors. PLoS One 2008, 3(9):e3146.
247. Zaitseva L., Cherepanov P., Leyens L., Wilson S.J., Rasaiyaah J., Fassati A. HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology 2009, 6:11.
248. Zhai Q., Fisher R.D., Chung H.Y., Myszka D.G., Sundquist W.I., Hill C.P. Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV. Nat. Struct. Mol. Biol. 2008, 15(1):43-49.
249. Zhang L., Huang Y., He T., Cao Y., Ho D.D. HIV-1 subtype and second-receptor use. Nature 1996, 383(6603):768.
250. Zhang Y., Lou B., Lal R.B., Gettie A., Marx P.A., Moore J.P. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J. Virol. 2000, 74(15):6893-6910.
251. Zhou H., Xu M., Huang Q., Gates A.T., Zhang X.D., Castle J.C., Stec E., Ferrer M., Strulovici B., Hazuda D.J., Espeseth A.S. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4(5):495-504.
252. Zhou M., Deng L., Lacoste V., Park H.U., Pumfery A., Kashanchi F., Brady J.N., Kumar A. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription. J. Virol. 2004, 78(24):13522-13533.
253. Zhou M., Huang K., Jung K.J., Cho W.K., Klase Z., Kashanchi F., Pise-Masison C.A., Brady J.N. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. J. Virol. 2009, 83(2):1036-1044.
254. Zhou Q., Chen D., Pierstorff E., Luo K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 1998, 17(13):3681-3691.
255. Zhou Q., Sharp P.A. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 1996, 274(5287):605-610.
256. Zimmerman C., Klein K.C., Kiser P.K., Singh A.R., Firestein B.L., Riba S.C., Lingappa J.R. Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 2002, 415(6867):88-92.
257. Zolotukhin A.S., Felber B.K. Mutations in the nuclear export signal of human ran-binding protein RanBP1 block the Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1. J. Biol. Chem. 1997, 272(17):11356-11360.